This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Eastman Kodak, Rambus: After-Hours Trading

NEW YORK ( TheStreet) -- Shares of Eastman Kodak (EK) leapt in late trades on Thursday after the company agreed to divest its Eastman Gelatine business and named Laura Quatela president.

Eastman Kodak is selling the business, which has roughly 95 employees and makes gelatin used in photographic movie film and paper emulsions, to Rousselot, which is part of the Vion Food Group. Financial terms weren't disclosed.

Kodak said Quatela, who most recently served as general counsel, will serve as president alongside current president Philip Faraci, and that both will report to CEO Antonio Perez.

The stock was last quoted at 77 cents, up 22%, on volume of more than 400,000, according to Nasdaq.com.

Momenta Pharmaceuticals

Shares of Momenta Pharmaceuticals (MNTA - Get Report) surged in the extended session after the company inked a deal to collaborate with Baxter International (BAX - Get Report) on the development of follow-on biologics.

The deal calls for Baxter to make an upfront cash payment of $33 million to Momenta covering the initial collaboration on up to six follow-on biologic compounds. Momenta could receive additional payments based upon the development of the compounds and milestones reached. The parties expect to close the deal in the first quarter.

Momenta shares were last quoted at $18.10, up 6.4%, on volume of nearly 50,000, according to Nasdaq.com. Based on Thursday's regular-session close at $17.02, the stock was up more than 9% in the past year.

Rambus

A patent licensing agreement with Broadcom (BRCM - Get Report) sent shares of Rambus (RMBS - Get Report) higher in the after-hours session.

The five-year deal covers the use of Rambus-patented technology in Broadcom chips, and resolves litigation between the two parties. Financial terms weren't disclosed.

Rambus shares leapt nearly 8% to $7.89 in late trades on volume of 65,000, while Broadcom's stock was unchanged at $29.77.

-- Written by Michael Baron in New York.



>To contact the writer of this article, click here: Michael Baron.

>To submit a news tip, send an email to: tips@thestreet.com

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BAX $68.50 -0.38%
BRCM $43.30 -1.86%
MNTA $15.20 0.13%
RMBS $12.58 -0.28%
AAPL $124.43 -1.54%

Markets

DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs